FGF/VEGF gene therapy (Collateral)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFGF/VEGF gene therapy (Collateral)
Drug Alias NameVEGF/FGF gene therapy (Collateral)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionVascular endothelial growth factor receptor stimulantsFibroblast growth factor 4 modulators
TargetsFibroblast growth factor 4Vascular endothelial growth factor receptor
Therapy Area/IndicationsCoronary Artery DiseaseCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCollateral Therapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCollateral Therapeutics, Inc
Active IndicationsN/A
Inactive IndicationsCoronary Artery DiseaseCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A